Active-ingredient Dossier
Flecainide Acetate
Active-ingredient Dossier for Flecainide Acetate (class ic antiarrhythmic). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: FLECAINIDE
- Brand: APO-FLECAINIDE
- Brand: BPA-FLECAINIDE
- Brand: Flec-EM
- Brand: FLECAIN
- Brand: Flecainide
- Therapeutic area: Cardiology
What is
Flecainide Acetate Flecainide Acetate is a class IC antiarrhythmic agent.
Australian brands containing
Flecainide Acetate — FLECAINIDE — APO-FLECAINIDE — BPA-FLECAINIDE — Flec-EM — FLECAIN — Flecainide — FLECAINIDE MLabs — FLECAR — FLECATAB — TAMBOCOR
Therapeutic areas
Flecainide Acetate is registered in two therapeutic areas: Neurology (10 brands) and Cardiology (2 brands).
Sponsor landscape
The ingredient is marketed by ten sponsors: iNova Pharmaceuticals, Alphapharm, Arrotex Pharmaceuticals, AUBEX PHARMA, Emcure Pharmaceuticals, and Medsurge Pharma.
PBS and regulatory activity
One brand containing Flecainide Acetate has PBS-listed items, with the latest PBS schedule date of 1 May 2026.